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1. Introduction
Point-of-care (POC) diagnostics have been widely 
utilized for disease detection as they are fast, cheap 
and easy to use when compared to laboratory tests, 
which require highly trained staff, large/expensive 
equipment and can take several days to receive results 
[1]. These drivers have spurred rapid growth of POC 
diagnostic products in recent years with POC tests 
being particularly desirable in resource-limited 
settings [2], where convenient, rapid and widespread 
testing is required.
Rapid diagnosis in resource-limited settings is par-
ticularly relevant to diagnosis of hepatitis—a major
global health problem affecting almost 400 million 
people worldwide [3]. Hepatitis B virus (HBV) is a 
leading cause of liver disease and hepatocellular car-
cinoma (HCC), with almost 800 000 deaths attributed 
to HBV and related complications each year [4, 5]. In 
this work, a sensor for detection of the HBV has been 
developed, using the established biomarker for HBV 
acute or chronic infection: hepatitis B surface antigen 
(HBsAg).
Graphene, with its high conductivity, large sur-
face area and high electron transfer rate has been 
researched as a platform for electrical, electrochemical 
& other biosensing [6].
To produce an affinity graphene biosensor, the 
graphene surface needs to be bio-functionalized for 
specific biomarker detection [7]. First, the graphene 
surface must be modified with binding moieties able to 
attach a specific bioreceptor [8]. This can be achieved 
by using covalent (covalent bonds between radicals 
and the C  =  C bonds of pristine graphene [9], polym-
erization, cycloadditions or single-atom introduc-
tions [10, 11]) or non-covalent methods (electrostatic 
interactions, π–π stacking or Van de Waals interactions 
[12]). Specifically, in this work, non-covalent func-
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Abstract
A hybrid biosensor based on a graphene resistor functionalized with self-assembled Graphene-
AuNPs (Gold Nanoparticles) is demonstrated for the real-time detection of hepatitis B surface 
antigen (HBsAg). The hybrid biosensor consists of a ssDNA sequence attached to a graphene resistor 
device via π–π stacking interactions in combination with a ssDNA functionalized AuNP. The ssDNA 
has complementary sequences which through hybridization, yield the graphene-AuNP hybrid 
biosensor. Real-time 2-point resistance measurements, performed using varying concentrations of 
HBsAg, show a linear dependence of resistance change against the logarithm of HBsAg concentration 
(log[HBsAg]). A limit of detection of 50 pg ml−1 was observed. Moreover, the hybrid biosensor 
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tionalization was achieved via π–π stacking of single-
stranded deoxyribonucleic acid (ssDNA) to the gra-
phene surface.
DNA nucleobases are able to interact with gra-
phene via π–π stacking interactions, between the ring 
structures in the nucleobases and the graphene hex-
agonal units [13], as well as electrostatic interactions 
of DNA with the basal planes of graphene [12, 14]. 
Following successful functionalization of the gra-
phene surface, bio-functionalization—attaching bio-
receptors such as aptamers, antibodies, enzymes or 
mRNA probes—can be used to produce specific bio-
sensors. Graphene is highly sensitive to environmental 
changes and surface modifications. However, this also 
means it is highly sensitive to entities other than the 
target analyte, e.g. buffer solutions/complex matrices 
such as serum and water or other solvents. Therefore, 
background signals from the test solution can be high 
and potentially obscure the binding events of specific 
bioreceptor-target interactions. To enhance the signal 
from target-sensor interactions, gold nanoparticles 
(AuNPs) can be added to the sensor to create gra-
phene-AuNP hybrids. The AuNPs provide increased 
surface area for receptor binding and increased deflec-
tion angle of the bioreceptors, potentially reducing 
steric hindrance when compared to a planar surface, 
leading to amplified signals and higher sensitivity. 
Graphene–AuNP hybrid structures are of particular 
interest in biosensing applications because they dis-
play individual properties of graphene and AuNPs, but 
can also exhibit additional synergistic properties [15]. 
The presence of AuNPs on a graphene electrode facili-
tates a conductive interface with a large surface area, 
increased charge density and excellent biocompat-
ibility [16], promoting charge transfer at the ssDNA 
modified graphene interface [17]. Here we explore the 
use of graphene-AuNP hybrids in a real-time 2-point 
resistance measurement sensor for the detection of 
HBsAg.
Direct immobilization of biomolecules (e.g. pro-
teins) onto graphene has been reported to be unstable, 
with frequently applied washing steps during biosen-
sor fabrication readily removing proteins [18]. Gra-
phene decorated with AuNPs may suffer from these 
same issues if the AuNPs are simply physisorbed. 
Therefore, a more permanent, stronger and/or tar-
geted attachment of the AuNPs to the graphene surface 
is required for biosensing applications. Decoration of 
graphene to produce graphene-AuNP hybrids can be 
achieved with either in situ (physical vapour deposi-
tion, electrochemical & hydro-thermal synthesis [18]) 
or ex situ methods. In the ex situ approach, nanopar-
ticles are synthesized in advance and subsequently 
decorated onto the surface of graphene [18], linked 
by either covalent or noncovalent interactions [19]. 
Self-assembly of graphene-AuNP hybrids using ex situ 
methods have advantages over in situ methods owing 
to more controlled particle size distribution and more 
monodisperse surface coverage [20]. The decoration 
was achieved here through an ex situ approach. The 
π–π stack binding energies are strong enough to form 
at room temperature, higher binding energies between 
π–π stacked ssDNA and graphene when compared 
to that of H-π interactions between water molecules, 
negate solvent effects [21] and the graphene-AuNP 
hybrids can be manufactured in aqueous media, under 
ambient conditions.
In this work, the AuNPs are pre-functionalized 
with both monoclonal anti-HBsAg antibodies and a 
thiol modified ssDNA sequence. The AuNPs are then 
tethered to the graphene surface via DNA oligonu-
cleotide hybridization with part of a complementary 
ssDNA sequence—the other part of which is bound 
to the graphene substrate via π–π stacking (figure 1). 
The AuNPs anchored to the graphene surface consti-
tutes the graphene-AuNP hybrid biosensor, which 
can be utilised for HBsAg detection. This methodol-
ogy could be applied to any bioreceptor, making it an 
interchangeable and potentially universal platform for 
sensing applications.
2. Materials and methods
2.1. Materials
Graphene on 300 nm thermal oxide SiO2/Si wafers 
supplied by Graphenea. Photoresists: Microchem 
LOR 3A positive photoresist; Microposit S1805 G2 
Positive resist; Microposit MF-CD-26 developer and 
Figure 1. Graphene-AuNP hybrid: AuNPs co-functionalized with monoclonal anti-HBsAg antibody and ssDNA sequence 
2 incubated with the ssDNA functionalized (sequence 1) graphene. The part-sequence is hybridized to dsDNA while poly T 
section remains π–π stacked to the graphene, anchoring the particle to the surface.
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Microposit Remover 1165 purchased from DOW 
Electronics Materials. Dielectric paste supplied by 
Sun Chemical Corporation D1240114D5. Gold 
nanoparticles (60 nm) purchased from BBI Solutions 
Ltd.
All ssDNA sequences purchased from Eurogen-
tec. Monoclonal anti-HBsAg & HBsAg analyte pur-
chased from Hytest Ltd. OMNIPUR® DEPC treated 
water (nuclease- free) purchased from Sigma Aldrich 
company Ltd. Bovine serum albumin purchased from 
Sigma Aldrich company Ltd. Phosphate buffered 
saline purchased from Fisher Scientific UK Ltd. All 
other reagents purchased from sigma Aldrich Com-
pany Ltd and were of analytical grade.
All ssDNA sequences were diluted to stock concen-
tration in OMNIPUR® nuclease-free water and stored 
at  −20 °C before use.
2.2. Graphene device manufacture
Graphene resistor devices were fabricated using CVD 
(chemical vapour deposited) monolayer graphene 
on 300 nm thermal oxide SiO2/Si wafers (p-type, 
〈1 0 0〉-oriented). Devices consisted of a patterned 
graphene channel connected at either end to a stacked 
Cr/Pd metal contact. The graphene channels were 
patterned using photolithography and subsequently 
etched using an O2 plasma. The metal contacts were 
deposited using physical vapour deposition, 30 nm 
Cr & 200 nm Pd (using a Kurt J Lesker PVD75). The 
metal electrodes were passivated using screen-printed 
dielectric ink, with a window in the passivation layer, 
enabling exposure of the graphene channel. Details of 
device manufacture and passivation can be found in 
supplementary information.
2.3. Graphene-AuNP hybrid manufacture
60 nm AuNPs were co-functionalized, firstly with 
monoclonal anti-HBsAg antibody by physisorption 
and secondly, using a thiol modified ssDNA sequence 
(sequence 2: 5′ SH-TTTTTTTTTCGGATTCTA-
GAAATTCTTAACTATTTAATC 3′) attached to the 
AuNPs using S–Au bonding. 10% tween 80 solution 
was added to 1 ml of OD 1 (Optical Density of 1) 
AuNP/monoclonal anti-HBsAg conjugate and incu-
bated at room temperature for 30 min. The salt content 
of the solution was increased to a final concentration of 
0.1 M with PBS, followed by the addition of sequence 2 
ssDNA, incubating at 50 °C for 1 h 20 min [22]. Excess 
antibody and ssDNA were removed by centrifugation 
(4000 rcf for 3 min). The supernatant was removed, 
and the pellet was resuspended in 1  ×  PBS (pH 7.4) to 
~10  ×  concentration. The ssDNA sequence (sequence 
1: 5′ TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT-
GATTAAATAGTTAAGAATTTCTAGAATCCG 3′) 
used to functionalize the graphene resistor device, was 
dropped on to the graphene channels (20 µl of 100 µM 
solution in nuclease-free water) and incubated over-
night at 2–8 °C. Samples were then washed multiple 
times in 1  ×  PBS buffer (pH 7.4) to remove any ex-
cess ssDNA. The wash step consisted of 200 µl of PBS 
buffer (pH 7.4), delivered via pipette and gently dried 
with nitrogen (N2), repeated three times. The ssDNA 
sequence 1 is 60 nucleobases in length. This length 
was chosen to enable the poly T (poly thymine) sec-
tion of the sequence to π–π stack on to the graphene 
surface, while the remaining part-sequence is available 
for hybridization with sequence 2 bound to the AuNP. 
Hybridization of the two ssDNA part sequences to ds-
DNA (double stranded DNA) tethers the AuNP to the 
graphene surface. Computational studies have inves-
tigated the binding energies of individual nucleobases 
in order to determine the strength of interaction of the 
different nucleobases with graphene [23].
It has been demonstrated that a poly A (poly Ade-
nine) sequence can form spherical particles on the 
graphene surface whereas poly T remains flat [24]. 
Hence, a poly T part-sequence was used to π–π stack to 
the graphene surface. The other portion of sequence 2 
consisted of a 30-nucleobase length, bound at its thiol 
termination to the AuNPs. This 30-base part sequence 
was chosen as it is long enough to hybridize with 
sequence 1 on the graphene surface but short enough 
not to hinder the binding capability of the monoclo-
nal anti-HBsAg antibody also present on the AuNP 
surface. Hybridization of graphene-bound ssDNA 
sequence 1 with the sequence 2 ssDNA-AuNP, yield-
ing a dsDNA structure, increases the number of nucle-
obases in the vicinity of the graphene channel and also 
detaches the bases from the surface of graphene [25]. 
Both situations will affect the level of doping of the 
graphene channel, caused by the nucleobases and also 
by the bound AuNP conjugate.
The AuNP/monoclonal anti-HBsAg/ssDNA func-
tionalized conjugate was diluted to OD2 in PBS (pH 
7.4) and incubated on the ssDNA (sequence 1) func-
tionalized graphene for 2.5 h at room temperature. 
Samples were washed with PBS (pH 7.4) as described 
above. Bovine serum albumin (BSA) was used to 
block any remaining sites on the graphene surface to 
avoid non-specific binding, using a 1% BSA solution 
(in deionized water) incubated on the graphene sur-
face for 30 min at room temperature. Excess BSA was 
removed by washing with PBS (pH 7.4).
2.4. Real-time 2-point resistance measurements
Graphene resistor devices with three CVD single-
layer graphene channels on a SiO2/Si substrate 
were used for sensitive real-time 2-point resistance 
measurements. A connector (supplied by Biovici 
Ltd) was used to provide electrical connections 
between graphene channels and measurement 
instruments (Supplementary Information, figure S1 & S5 
(stacks.iop.org/TDM/7/024009/mmedia)). All three 
graphene channels were measured simultaneously 
using a standard lock-in technique. Current- fixed 
and voltage-fixed measurement regimes were used 
throughout. Currents of 0.1 or 1.0 µA were passed 
through the channels in a current-fixed regime. Fixed 
2D Mater. 7 (2020) 024009
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voltages of 0.1 or 4 mV were applied to the channel 
contacts when the voltage-fixed regime was used. The 
obtained values of the resistances were insensitive to 
the measurement method. All measurements were 
performed in ambient conditions (temperature 20 °C, 
and at normal atmospheric pressure).
3. Results & discussion
3.1. Characterization of functionalized AuNPs
A UV–vis absorption scan was carried out using 
a BMG LABTECH FLUOstar Omega Microplate 
Reader at wavelengths between 450–650 nm, with 
measurements taken at 1 nm intervals. Absorbance 
spectra were measured for bare 60 nm AuNPs and 
functionalized 60 nm AuNPs (figure 2(a)).
The UV–vis absorbance spectra show a slight red-
shift of the peak absorbance (λmax) after co-function-
alization with monoclonal anti-HBsAg and ssDNA 
sequence 2 (λmax  =  535 nm for bare 60 nm AuNPs 
and 539 nm for functionalized AuNPs). The red-shift 
in λmax is due to a change in the local refractive index 
owing to the attachment of antibody & ssDNA to the 
particle surface. The λmax shift observed is comparable 
to those reported in the literature [26, 27], which can 
be used to confirm antibody attachment to the particle 
surface [28]. The spectra for the functionalized AuNPs 
is also slightly broader when compared to bare AuNPs, 
also indicating attachment of materials to the surface 
[29].
Dynamic light scattering (DLS), carried out using 
a Malvern Nano ZS Zetasizer, showed an increase in 
hydrodynamic diameter (DH) between bare and func-
tionalized AuNPs (figure 2(b)). The DH increased 
from 65.09  ±  0.27 nm to 91.61  ±  0.82 nm, confirming 
the attachment of monoclonal anti-HBsAg and ssDNA 
to the AuNP surface. This increase in DH is consistent 
with literature values [29]. Low poly dispersity index 
(PdI) values and the presence of only one peak (see 
supplementary information) indicates the functional-
ized AuNPs are not aggregated and are stable in solu-
tion. Verification of ssDNA attachment to AuNPs was 
carried out using a lateral flow assay, results can be seen 
in supplementary figure S4.
3.2. Characterization of graphene-AuNP hybrids
Raman spectroscopy using a 532 nm excitation was 
performed on the graphene channels at each stage 
of functionalization (pristine graphene, ssDNA 
(sequence 1) functionalized, hybridization with 
Figure 2. (a) UV–vis absorption spectra for bare 60 nm AuNPs (black) and monoclonal anti HBsAg/ssDNA co-functionalized 
60 nm AuNPs (red) (b) DLS distribution by intensity for bare AuNPs (black) and monoclonal anti- HBsAg/ssDNA co-
functionalized 60 nm AuNPs (red). Results obtained from an average of 3 measurements consisting of 13 runs per measurement.
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co-functionalized AuNP, and final BSA blocking). 
Mapping scans across the graphene channel were 
taken, with 104 scans obtained across a 120  ×  70 µm 
area. Representative spectra are shown in figure 3(a). 
The Raman spectrum of the pristine graphene channel 
is similar to that of pristine graphene reported in the 
literature [30], with a G-mode at ~1590 cm−1 and 
2D mode at ~2700 cm−1. The intensity ratio of these 
two peaks (I2D/IG  =  ~2), as well as the full width half 
maxima of the 2D mode peak (FWHM2D  =  18) 
indicate that the graphene is a monolayer [31].
The 2D mode for all spectra collected were fitted 
with a Lorentzian curve and the position of the peaks 
taken from the fitted data. Figure 3(b) shows a boxplot 
of the 2D peak positions at each step of the function-
alization process. The pristine graphene shows a 2D 
mode distribution with an average of 2677 cm−1. Four 
outliers are observed and are attributed to defects and 
polymer contamination affecting the local graphene 
electronic and vibrational structure [32]. The mean 
peak position shifts from the 104 spectra significantly 
after functionalization with ssDNA to 2684 cm−1, with 
further, more subtle shifts to 2692 cm−1 upon intro-
duction of the AuNPs. Introduction of the blocker 
BSA shifts the peak slightly in the opposite direction, to 
2690 cm−1. This is consistent with doping via electron 
transfer to the graphene and agrees with the resistance 
measurements shown in figure 7.
The graphene channel prior to functionalization 
has p-type conductivity. Slight n-doping via electron 
donation from the ssDNA reduces the conductivity, 
and a further reduction is observed after functionali-
zation with the AuNPs. The slight recovery of the con-
ductivity upon introduction of the BSA could be due 
to some of the AuNPs/ssDNA being washed off the 
surface during the final washing step.
AFM-IR, a form of photothermal chemical charac-
terization was performed on two samples, an unfunc-
tionalized graphene channel and a channel after deco-
ration with AuNPs and ssDNA. Samples were scanned 
topographically to determine regions of interest (fig-
ure 4) and spectra (850–1200 cm−1) were obtained 
(figure 5) for functional material on the surface before 
the sample was rescanned, whilst excited at the wave-
length of interest, in this case 1100 cm−1, and an AFM-
IR intensity map obtained.
From the spectra in figure 5, the pristine channel 
shows peaks around 1020–1034 cm−1, attributed to 
Figure 3. (a) Raman spectra for each functionalization stage. (b) Boxplot of 2D mode positions for each functionalization stage.
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the underlying SiO2 substrate. Upon introduction of 
the AuNPs and ssDNA, these peaks are suppressed in 
favour of peaks at 1060 cm−1 and 1110 cm−1. Com-
paring to an FTIR spectrum of an aqueous dispersion 
of ssDNA, the peaks were attributed to the ssDNA 
phosphate stretching modes [33]. A further peak at 
1030 cm−1 is assigned to the C–O in the furanose 
group in the ssDNA—as seen in the FTIR spectrum 
[34]. A peak at 960 cm−1 in the FTIR is attributed to 
O–P–O bending [33] which is not present in the AFM-
IR spectra due to the requirements on the technique 
for thermal expansion for chemical detection. How-
ever, the appearance of the furanose (a five-member 
ring of four carbons and one oxygen) and phosphate 
stretching peaks indicate that ssDNA is present on 
the surface of the graphene channel, demonstrating 
 successful functionalization. A decrease of the I2D/IG 
ratio, combined with a blueshift of the 2D mode sug-
gests charge transfer to the graphene layer.
An intensity map of absorption at 1100 cm−1 
shows the distribution of functional material on the 
surface, with aggregation clearly visible, creating a 
 heterogeneous covering on the graphene channel. This 
is in agreement with the large range of the Raman 2D 
mode positions for this sample, as doping via surface 
moieties causes local electronic perturbations of the 
graphene. Areas of graphene, not covered by functional 
material, show smaller shifts of the 1100 cm−1 peak.
Figure 4. Top: Topography of a ssDNA/AuNP coated graphene channel. Bottom: AFM-IR amplitude scan of the same area, with IR 
excitation at 1100 cm−1.
Figure 5. FTIR and AFM-IR spectra of ssDNA and non-functionalized and ssDNA-functionalized graphene.
2D Mater. 7 (2020) 024009
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SEM images (figure 6) show even particle distri-
bution on the graphene surface and indicates that the 
particles attach to the functionalized graphene only 
and not to the surrounding SiO2 substrate.
Validation of antibody/antigen binding and 
attachment of monoclonal anti-HBsAg to AuNPs was 
carried out using a lateral flow assay (see figure S3).
3.3. Real-time 2-point resistance measurement of 
surface functionalization
Real-time 2-point resistance measurements at each 
stage of graphene functionalization are shown in 
figure 7.
Real-time resistance measurements, includ-
ing relaxation periods which may be associated with 
charge redistribution of the graphene between the 
charges related to the surface absorbates on one side 
and those related to the SiO2/Si substrate on the other 
[35], were performed on all three graphene channels 
which show similar behaviour. Each functionaliza-
tion stage shows an increase in resistance after relaxa-
tion when compared to the previous functionalization 
stage. A significant difference in channel resistance 
between the ssDNA (sequence 1) stage and the mono-
clonal anti-HBsAg/ssDNA functionalized AuNP stage 
is observed. The final resistance, after BSA and final 
wash steps, also shows this trend of increased resist-
ance compared to the initial baseline.
Measurements using the same electrical conditions 
were also carried out with a physisorbed control sam-
ple, where the graphene surface was not functionalized 
with ssDNA prior to addition of the AuNP/mono-
clonal anti-HBsAg/ssDNA functionalized particles. 
Channel resistances, ΔRch/R0 ch, were monitored for 
Figure 6. SEM imaging of AuNPs on graphene (a) AuNP attachment to graphene channel versus substrate (image taken at the edge 
of the graphene channel). (Inset) Measurement confirms the AuNP size as 60 nm.
Figure 7. Real-time channel resistance measurements of graphene functionalization process. Where ΔR  =  Rchannel  −  R0, and R0 is 
the initial resistance measurement.
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each functionalization and wash steps (figure S6). Suc-
cessful decoration of the graphene with receptors spe-
cific to HBsAg thus allows for sensing to be performed.
3.3.1. Real-time 2-point electrical detection of HBsAg
HBsAg sensing was performed using sequential 
measurements with increasing HBsAg (molecular 
weight ~24 000 Da) concentration on the same 
graphene resistor device. Each concentration 
measurement consisted of a 20 µl droplet of HBsAg 
(diluted in 1  ×  PBS (pH 7.4)) solution with increasing 
concentrations between 0–1000 pg ml−1, placed on 
the channel window of the functionalized graphene 
device. This exposed device was incubated for 15 min 
at room temperature, followed by standard washing (as 
detailed in the methods section). The functionalized 
channels were allowed to relax for 45 min and the 
resistance was monitored in real-time throughout this 
process. After relaxation, a droplet with higher HBsAg 
concentration was applied and the resistance change 
of the device monitored. Figure 8(a) (top) shows 
the resistance responses, ΔRch/R0 ch, with respect 
to varying HBsAg concentrations. It was observed 
that the ΔRch/R0 ch signal reached a level of 0.6 even 
at 0 pg ml−1 concentration (indicating a background 
response of the graphene channel device to the test 
buffer solution) of HBsAg, with a gradual increase in 
resistance with increasing HBsAg concentration. The 
concentration sensitive area in the response signal is 
marked by dashed lines in figure 8(a) (top).
Background signal responses in graphene devices 
can be affected by both intrinsic, e.g. grain boundaries 
in CVD grown graphene, and extrinsic factors (includ-
ing polymer residues [36]), leading to device-to-device 
variations [37]. Figure 8(a) gives an example of device-
to-device variation with the signal strength at 0 pg 
ml−1 varying between the positive HBsAg and the neg-
ative BSA, even though the same PBS (pH7.4) buffer 
was used for both measurements. Grain boundaries 
are expected to be more reactive than the basal plane 
of the graphene and could accumulate absorbed mol-
ecules/particles & contaminants more readily [38]. In 
general, a combination of intrinsic & extrinsic factors 
is likely to contribute to differences in device-to-device 
signal response. Additionally, AuNP distribution and 
BSA blocker coverage on the graphene surface could 
Figure 8. (a) Graphene channel resistance response with respect to the time- dependent application of various HBsAg 
concentrations in pg ml−1 (top) and at various BSA concentrations in pg/ml (bottom). Where ΔR  =  Rchannel  −  R0 channel, and R0 
channel is the initial resistance measurement. (b) Normalized graphene channel resistance against log HBsAg concentration. An 
experimental limit of detection (LOD) was measured as an increase of the resistance above this horizontal region at  >50 pg ml−1.
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also contribute to variations in the device-to-device 
performance. Therefore, normalized resistances must 
be used.
Normalized resistances for all three channels are 
plotted against time for increasing HBsAg concen-
trations (figure 8(a) (top)). The measured graphene 
resistance was normalized using the resistance value 
measured at time t  =  0. The same procedure was used 
to measure changes in response to BSA, as a negative 
control sample. A negative control protein was used 
to test for non-specific responses of the sensor and to 
control for any cumulative effects of the sequential 
testing regime. Normalized resistances for all three 
channels against time for increasing BSA concentra-
tions are plotted in figure 8(a) (bottom). Figure 8(a) 
(top) shows a rise in ΔRch/R0 ch with increasing HBsAg 
indicating concentration dependence. The resistance 
was recorded as a function of time, the addition of 
HBsAg sees only a further increase in resistance, from 
that at the functionalization stage, suggesting a charge 
transfer of electrons to the graphene. In contrast, fig-
ure 8(a) (bottom) shows no concentration depend-
ence for the negative control protein (BSA).
Normalized channel resistance plotted against log 
concentration of HBsAg is shown in figure 8(b), the 
lowest detection limit was determined as the intersec-
tion of the baseline at the lowest concentrations and 
the linear approximation of the experimental values 
at higher antigen concentrations. Both fitted lines are 
plotted through the average resistance values for the 
three channels. Taking into account the specific noise 
of the experimental data, the detection threshold is 
shifted to a higher concentration value, with an exper-
imental LOD of 50 pg ml−1 (2.08  ×  10−12 mol l−1), 
this is comparable to current tests with LOD ranges 
between 0.04–0.62 ng ml−1 [39]. Similar results were 
observed for a further nine graphene channels.
To confirm that the negative response signals for 
the BSA control are true negative results and not a 
result of a faulty graphene device, HBsAg was added to 
the negative control sample device after all of the BSA 
concentrations had been applied. Following the final 
application of 1000 pg ml−1 BSA and standard wash 
steps, the sensor was allowed to relax overnight. 20 
µl of 1000 pg ml−1 HBsAg was placed onto the chan-
nel window and incubated at room temperature for 
15 min. In response to this, the relevant changes in 
channel resistances (figure 9) were remarkably differ-
ent from the changes observed for the BSA negative 
control measurements. The introduction of HBsAg 
produced resistance changes similar to that observed 
for the HBsAg positive sample, figure 8(a) (top), dem-
onstrating the specific detection of the HBsAg bio-
marker.
4. Conclusions
A graphene device has been demonstrated for real-time 
detection of HBsAg using a hybrid graphene-AuNP 
platform. Functionalized AuNPs were successfully 
decorated onto graphene via π–π stacking of ssDNA 
and part-hybridization of a graphene anchored 
ssDNA sequence with a ssDNA functionalized AuNP. 
The resultant dsDNA link creates the hybrid graphene-
AuNP. Decoration of the graphene was observed with 
no attachment of particles to the SiO2 surrounding 
substrate. Real-time 2-point resistance measurements 
showed each stage of functionalization produced an 
increase in resistance. HBsAg was successfully detected 
as an increase in ΔRch/R0 ch with increasing HBsAg 
concentration. A limit of detection of 50 pg ml−1 
(2.08  ×  10−12 mol l−1) was observed. BSA was used 
as a negative control protein with no concentration 
dependence observed for the graphene resistor. The 
Figure 9. Graphene real-time measurement of channel resistances after application of BSA (1000 pg ml−1) at time range less than 
600 min, standard wash steps with N2 drying, dry measurement between 600–1400 min and after HBsAg (1000 pg ml−1) at 1400 min. 
The inset demonstrates the detailed time response to HBsAg application.
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graphene sensor was successfully demonstrated 
for the detection of HBsAg, acute and/or chronic 
biomarker for HBV. The platform may be used in 
future for detection of other biomarkers, making it an 
interchangeable and potentially universal platform for 
sensing applications.
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